Leadership

Susan Murphy

Susan was appointed President of Molecular Devices in June 2019. She joined the company in 2002 in a scientific engineering role and held positions in both the Life Science and Drug Discovery Sales Organizations. She moved into sales management in 2007, progressing through a series of sales leadership roles with increasing commercial responsibilities for North America, Europe, and Brazil. Most recently, she served as Vice President & General Manager of commercial operations in western markets, where she led sales and all aspects of global marketing.

Prior to Molecular Devices, Susan worked at PerkinElmer and Packard BioScience. She also held multiple research positions at Penn State Medical School, University of Chicago, Mount Desert Island Biological Laboratories, and Lake Forest College. Susan graduated with a BA in Biology from Lake Forest College, IL and completed graduate coursework at University of Illinois at Chicago in the Molecular, Cell & Developmental Biology Program.

Steven Qian

Steven joined Molecular Device in March 2019 as CFO for the company. Prior to joining Molecular Device, Steven has been with Beckman Coulter Diagnostics as VP Finance for High Growth Markets where he had responsibility in supporting the growth of a region consisting of 150 countries and $1.4B revenue. Steven first joined Danaher with Fluke Corporation as their Asia Finance Director in 2004. In 2013, Steven assumed responsibility for Danaher Corporate Vice President of Finance-Asia CFO. Prior to joining Danaher, Steven worked with Citigroup, i2 Technologies, PepsiCo in progressing roles. Steven is a licensed CPA in State of Texas and holds a B.S. degree majoring in Accounting from Indiana University at South Bend, a Master of Science in Engineering from Southern Methodist University as well as an EMBA from Tsinghua University in Beijing.

Martin Verhoef

Martin joined Molecular Devices in August 2013. Over the prior 10 years Martin held President and CEO positions in start-ups including Ciphergen BioSystems, PrimeraDx, MiraDx and Applied BioCode. Previously he held leadership roles in sales, marketing and R&D with Agilent and Pharmacia. Martin holds a double BS in Clinical and Analytical Chemistry from the van‘t Hoff Institute, Rotterdam, The Netherlands.

Poonam Taneja, Ph.D.

Poonam started in her current role in July 2010. From 2006 to 2010, Poonam held the position of Director, Global Distribution and was responsible for the company’s business in India, South East Asia, Middle East, Russia, Eastern Europe and Latin America. Poonam’s previous positions include Director of International Sales at Arcturus Bioscience and Alpha Innotech Corporation. Previously, Poonam held research positions in Italy, Germany and the US in molecular and cellular biology. Poonam holds a Doctorate in Chemistry from Delhi University and an MBA from Vanderbilt University.

Laurent Claisse

As VP/GM of Biologics Business Unit, Laurent is responsible for all activities related to the Biologics Business Unit for North America, Europe and Asia. He joined Molecular Devices in 2019 from Pall Corporation, another Danaher company, where he held different positions in the Pall Industrial division. Prior to Pall Corporation, Laurent held management positions in some others Danaher Operating companies such as Danaher Sensors & Controls, Fluke Biomedical & Veeder Root. Laurent graduated with a MBA from HEC Paris, a master in Strategy from IFG Paris and a degree in Process Automation.

Dean Ding

Dean joined Molecular Devices in June 2010 and was appointed Vice President of Global Operations in Apr.2017. Prior to his current role, he was the General Manager of Molecular Devices’ Shanghai, China plant. Dean has held multiple manufacturing leadership and General Manager roles in companies like General Electric, PerkinElmer, Donaldson and Siemens. He holds a BA in Mechanical Engineering from East China University of Science & Technology, and a Master’s degree in Industrial & Systems Engineering from National University of Singapore.

Jim Reutlinger

Jim was appointed Vice President of Global Professional Services in January of 2018 and previously served as the Director of the Americas & Oceania Service and Service Sales since January of 2015. Prior to joining Molecular Devices, Jim held a variety of leadership roles at Sciex including Director of Global Service Operations. Previous to Sciex, his experience included numerous leadership roles over the last 15 years at Applied Biosystems and Life Technologies including leading Customer Support as well as Chief of Staff to the President & COO. Jim holds a BS in Business and Marketing Management from California State University, East Bay.

John Olson

John started his current position in April 2013. From 2010 to 2013, he was Director of Manufacturing for the company’s US and Europe plants. Prior to this, John held multiple positions in Operations, running all aspects of both reagent and instrument operations in the US, China and Europe. John joined Molecular Devices in 1986 in R&D, helping develop the Threshold assay system as well as other assays and instruments. Prior to Molecular Devices, John worked in the Research and Development departments at Syva, the diagnostic arm of Syntex Corporation. John graduated with a BA from UC Santa Cruz with a double major in biology (with honors) and chemistry.

Julia Daneman

Julia is serving as Lead Legal Counsel of Molecular Devices since November 2016 and has been with the company progressing through a series of roles in the legal team since March 2012. Over the prior 15 years, Julia held legal positions at Trimble, a manufacturer of advanced positioning solutions, @Road, a provider of mobile resource management solutions, and business development positions in Ukraine. Julia is admitted to practice law in California. She holds a Master of Laws from Santa Clara Law School, a law degree with specialization in International Law from Taras Shevcheko National University of Kyiv, Ukraine, and a B.A from Taurida National V.I. Vernadsky University, Ukraine.